pneumonia
count
among
group
widespread
diseas
lower
respiratori
tract
infect
belong
five
common
caus
death
worldwid
global
burden
diseas
studi
high
burden
diseas
consequ
entail
great
econom
burden
gener
public
welt
et
al
pneumonia
sever
inflammatori
condit
lung
affect
primarili
peripher
alveolar
compart
clinic
patient
suffer
product
dri
cough
chest
pain
fever
compromis
respir
simpl
pneumonia
may
progress
lifethr
condit
subsequ
respiratori
failur
system
inflamm
bauer
et
al
usual
infect
virus
bacteria
less
commonli
microorgan
caus
pneumonia
despit
applic
vaccin
strategi
pathogen
commonli
caus
pneumonia
streptococcu
pneumonia
mehr
wood
scott
et
al
influenza
viru
iav
ortiz
et
al
avail
pathogen
still
caus
tremend
morbid
mortal
worldwid
furthermor
antibiot
resist
emerg
problem
infecti
diseas
per
se
brown
wright
risk
factor
pneumonia
compris
lung
diseas
cystic
fibrosi
chronic
obstruct
pulmonari
diseas
copd
asthma
includ
problemat
condit
diabet
heart
failur
histori
smoke
alcohol
abus
torr
et
al
addit
children
younger
year
age
walker
et
al
peopl
older
year
torr
et
al
higher
risk
develop
pneumonia
investig
hostpathogen
interact
especi
human
lung
tissu
key
develop
new
intervent
strategi
pneumonia
classic
cell
cultur
model
use
mechanist
function
analysi
onetoon
interact
cell
microb
expand
version
second
implement
cell
type
could
exampl
reflect
simpl
influenc
addit
host
factor
howev
basic
vitro
system
neither
reflect
tissu
divers
cellular
level
recapitul
typic
alveolar
cellcel
interact
natur
matrix
eg
alveolar
epitheli
cell
aec
interact
aecii
capillari
endothelium
threedimension
architectur
therefor
research
would
like
investig
cellular
tropism
viru
caus
pneumonia
realist
model
possibl
cell
type
form
potenti
habitat
present
dish
frequent
passag
primari
immort
cell
bronchial
epitheli
ke
et
al
tumorderiv
cell
alveolar
cell
smith
use
proteas
trypsin
cell
split
may
lack
central
biolog
characterist
import
hostpathogen
interact
includ
exampl
capabl
form
tight
junction
rothenrutishaus
et
al
express
receptor
involv
pathogenbind
recognit
addit
use
wildtyp
encapsul
bacteria
limit
cell
cultur
cell
toxic
effect
capsul
n
guessan
et
al
schmeck
et
al
motiv
research
use
unencapsul
laboratoryderiv
strain
sinc
pathogen
exampl
serotyp
pneumonia
major
caus
pneumonia
bauer
et
al
bogaert
et
al
drijkoningen
rohd
jefferson
et
al
capsulerel
effect
enorm
signific
virul
tissu
invas
geno
et
al
use
origin
encapsul
patientderiv
strain
import
realist
model
pathogenhost
interact
anim
mice
repres
integr
model
modern
genet
anim
manipul
allow
sophist
analysi
hostpathogen
interact
includ
lung
baron
et
al
hraiech
et
al
thangavel
bouvier
nevertheless
signific
differ
anatomi
innat
adapt
immun
long
known
exist
human
particular
small
rodent
mesta
hugh
mani
result
obtain
model
translat
human
remain
unclear
mak
et
al
respect
investig
infecti
diseas
rodent
includ
pneumonia
major
problem
host
specif
pathogen
bean
et
al
bouvier
gretebeck
subbarao
sutton
subbarao
ware
wolf
et
al
exampl
human
nasopharynx
seem
repres
natur
reservoir
pneumonia
bogaert
et
al
kadioglu
et
al
rare
observ
pathogen
wildlif
speci
without
contact
human
document
chi
et
al
anim
model
ferret
guinea
pig
natur
suscept
infect
human
influenza
strain
iav
other
mice
requir
adapt
viru
bouvier
particular
major
iav
research
mice
employ
either
balbc
strain
conjunct
laboratori
adapt
apuerto
wsn
adapt
pathogen
anim
model
speci
involv
serial
passag
increas
virul
procedur
inevit
alter
pathogen
behavior
emerg
viral
lung
diseas
sever
acut
respiratori
syndrom
coronaviru
sarscov
peiri
et
al
poon
et
al
middl
east
respiratori
syndrom
coronaviru
merscov
fehr
et
al
mohd
et
al
zumla
et
al
new
iav
strain
infect
human
eg
lai
et
al
novel
swineorigin
influenza
et
al
peiri
et
al
zhu
et
al
repres
classic
zoonot
diseas
indic
speci
use
research
great
import
noteworthi
although
exampl
iav
infect
broad
varieti
speci
infect
rodent
mice
natur
diseas
merscov
avail
anim
model
repres
human
clinic
diseas
gretebeck
subbarao
sutton
subbarao
lack
receptor
viral
bind
raj
et
al
forc
research
creat
complex
transgen
human
model
gretebeck
subbarao
sutton
subbarao
overal
order
investig
biolog
estim
virul
potenti
pathogen
need
complement
vitro
cell
cultur
studi
anim
studi
suitabl
humanderiv
model
follow
use
ex
vivo
cultur
infect
human
lung
investig
bacteri
viral
infect
discuss
direct
model
develop
reveal
pneumococci
frequent
colon
human
nasopharynx
bogaert
et
al
scott
et
al
seem
inde
primari
natur
habitat
import
human
pathogen
pneumonia
infect
anim
race
hors
rhesu
monkey
chimpanze
occur
mostli
anim
held
human
captiv
suspect
attribut
humananim
transmiss
chi
et
al
studi
search
caus
agent
pneumonia
pneumococci
frequent
isol
pathogen
outpati
ininpati
set
includ
sever
pneumonia
treat
intens
care
unit
drijkoningen
rohd
pneumonia
strain
differ
consider
capac
caus
diseas
human
gener
strain
may
primarili
caus
invas
diseas
wherea
other
predomin
induc
otiti
media
jefferson
et
al
mehr
wood
sinc
pneumococci
true
humanspecif
pathogen
high
clinic
import
high
divers
diseas
caus
variou
clinic
isol
urgent
need
studi
biolog
pathogen
human
tissu
ex
vivo
infect
human
lung
pneumococci
induc
express
immunomodulatori
molecul
tumor
necrosi
factor
granulocytemacrophag
colonystimul
factor
plateletderiv
growth
factor
pdgf
fatykhova
et
al
szymanski
et
al
xu
et
al
experi
perform
clodronateinduc
deplet
alveolar
lung
macrophag
indic
cell
might
particular
contribut
induct
xu
et
al
fatykhova
et
al
involv
use
variou
clinic
isol
investig
capac
induc
potent
proinflammatori
cytokin
clinic
strain
differ
express
cholesteroldepend
cytolysin
pneumolysin
pli
major
virul
factor
pneumococci
kadioglu
et
al
wherea
serotyp
pneumococci
express
fulli
hemolyt
pli
serotyp
strain
express
nonhemolyt
pli
fatykhova
et
al
author
demonstr
strain
express
lytic
pli
induc
manner
experi
purifi
allel
pli
capabl
caus
pore
allel
pli
caus
pore
verifi
pore
format
prerequisit
plyrel
induct
human
lung
tissu
addit
mechanist
inform
regul
human
lung
studi
highlight
suitabl
model
analyz
biolog
patientderiv
bacteri
isol
show
meaning
result
obtain
cyclooxygenas
cox
produc
fatti
acid
mediat
includ
prostaglandin
play
import
role
regul
lung
immun
claar
et
al
zhou
et
al
human
lung
pneumococci
induc
strong
upregul
induc
form
cox
name
particular
aecii
aeci
vascular
endothelium
notabl
result
seen
tissu
patient
suffer
pneumonia
szymanski
et
al
inhibit
mapk
mitogenactiv
protein
kinas
extracellular
signalregul
kinas
block
induct
releas
addit
author
show
releas
thromboxan
infect
tissu
tissu
express
predomin
e
prostanoid
receptor
stimul
result
increas
camp
product
lung
tissu
product
lung
cell
may
contribut
control
inflammatori
mediat
product
mortim
et
al
pneumococc
pneumonia
furthermor
xu
et
al
note
increas
express
tolllik
receptor
mrna
pneumococciinfect
tissu
howev
neither
way
translat
protein
express
effect
cell
known
accord
mean
observ
activ
signal
pathway
mapk
szymanski
et
al
xu
et
al
made
cellspecif
unknown
addit
pli
pneumococci
liber
signific
amount
hydrogen
peroxid
thu
reason
suggest
caus
oxid
stress
lung
kadioglu
et
al
howev
although
pneumococci
caus
oxid
stress
human
lung
evidenc
decreas
ratio
glutathion
glutathion
disulfid
infect
tissu
zahlten
et
al
seem
depend
oxygen
radic
unexpectedli
pneumococc
autolysin
lyta
depend
process
turn
induc
oxid
stress
lyta
major
autolysin
pneumococci
lopez
garcia
caus
releas
intrabacteri
compon
pli
bacteri
dna
sinc
pneumococcirel
express
immunomodulatori
transcript
factor
krueppellik
factor
klf
mcconnel
yang
human
lung
seem
also
depend
lytarel
pneumococc
autolysi
zahlten
et
al
klf
impact
lung
cell
activ
pneumococc
infect
zahlten
et
al
b
investig
lytarel
activ
lung
tissu
highli
recommend
abovement
studi
indic
strong
proinflammatori
mediat
releas
pneumococciinfect
lung
tissu
fatykhova
et
al
szymanski
et
al
xu
et
al
massiv
inflamm
particular
sever
pneumonia
suggest
foster
progress
diseas
acut
respiratori
failur
sepsi
multiorgan
dysfunct
bauer
et
al
quinolon
moxifloxacin
hypothes
exert
antiinflammatori
benefici
effect
addit
wellestablish
antimicrobi
properti
dalhoff
shalit
howev
investig
effect
moxifloxacin
pneumococci
releas
human
lung
tissu
et
al
found
releas
reduc
moxifloxacin
accompani
investig
pneumococc
mous
pneumonia
model
show
similar
result
thu
support
hypothesi
moxifloxacin
exhibit
potent
antiinflammatori
potenc
pneumococc
pneumonia
although
bacillu
anthraci
caus
pneumonia
lung
entri
site
b
anthraci
inhal
anthrax
deadli
form
diseas
seem
inhal
spore
escap
alveolu
region
lymph
node
therein
spore
may
germin
induc
diseas
reach
circulatori
system
moayeri
et
al
import
virul
factor
b
anthraci
includ
two
toxin
lethal
toxin
lt
edema
toxin
et
share
protect
antigen
pa
common
receptorbind
compon
pa
allow
transport
catalyt
compon
lf
ef
cytosol
target
cell
frieb
et
al
moayeri
et
al
chakrabarti
et
al
test
b
anthraci
sporerel
inflammatori
tissu
activ
util
spore
prepar
b
anthraci
stern
strain
signific
increas
monocyt
chemoattract
macrophag
inflammatori
protein
mip
note
lung
tissu
supernat
howev
although
tremend
upregul
mrna
document
author
note
increas
protein
nevertheless
supernat
sporeexpos
lung
tissu
stimul
neutrophil
monocyt
chemotaxi
b
anthraci
spore
caus
strong
activ
mapk
erk
jnk
chemic
inhibit
kinas
reduc
chemo
cytokin
liber
final
immunohistochemistri
reveal
presenc
epitheli
cell
overal
studi
chakrabarti
et
al
reveal
b
anthraci
spore
initi
promin
proinflammatori
respons
import
unresolv
question
b
anthraci
spore
escap
alveolar
airspac
system
circul
frieb
et
al
moayeri
et
al
principl
transport
might
occur
via
host
cell
use
trojan
hors
dendrit
cell
dc
hitherto
unidentifi
carrier
cell
spore
may
cross
alveolar
epitheli
wall
without
help
migratori
cell
final
sequenc
spore
cluster
germin
product
b
anthraci
virul
toxin
propos
caus
epitheli
damag
allow
free
spore
passag
frieb
et
al
goossen
tournier
moayeri
et
al
socal
jailbreak
model
weiner
glomski
use
abovement
model
chakrabarti
et
al
group
booth
et
al
aim
identifi
role
carrier
cell
b
anthraci
toxin
process
around
spore
intern
apc
around
aec
wherea
around
spore
free
h
postinfect
number
chang
time
importantli
cluster
spore
occur
infect
cell
clear
identif
aec
cell
take
spore
aec
aec
ii
mean
appropri
imag
techniqu
would
interest
interestingli
addit
pa
lt
neither
significantli
influenc
spore
uptak
caus
cytotox
spore
treatment
alon
also
overal
data
suggest
b
anthraci
spore
migrat
lung
soon
exposur
primari
initi
phase
spore
movement
alveolar
space
across
alveolar
epitheli
barrier
may
essenti
requir
cellular
carrier
howev
studi
show
transloc
spore
lung
blood
vessel
eg
alveolar
capillari
investig
requir
demonstr
presenc
spore
alveolar
cell
final
result
spore
movement
circul
mycobacteri
lung
infect
still
major
caus
morbid
mortal
worldwid
around
million
peopl
develop
tuberculosi
tb
million
peopl
die
chronic
infecti
lung
diseas
zumla
et
al
although
innat
immun
system
may
clear
earli
infect
tuberculosi
signific
number
case
khan
et
al
morrison
et
al
littl
known
initi
interact
import
pathogen
human
lung
tissu
ganbat
et
al
start
explor
interact
establish
ex
vivo
human
lung
infect
model
variou
mycobacteri
strain
tuberculosi
abscessu
avium
author
note
monocyt
neutrophil
aecii
cell
infect
mycobacteri
strain
interestingli
aecii
seem
infect
significantli
higher
frequenc
tuberculosi
abscessu
avium
present
result
indic
occurr
cell
death
infect
cell
type
also
differ
among
strain
although
studi
limit
rel
short
time
period
postinfect
h
postinfect
model
principl
allow
detail
analysi
initi
mycobacteriumalveolar
interact
includ
activ
inflammationregul
mediat
exampl
clinic
isol
thu
model
add
import
step
forward
investig
import
event
earli
mycobacteri
infect
nontyp
haemophilu
influenza
nthi
infect
particular
newli
acquir
strain
may
trigger
infectionrel
exacerb
copd
recurr
infect
may
induc
overal
diseas
progress
duell
et
al
use
nthi
strain
rd
isol
copd
patient
suffer
invas
pneumonia
wagner
et
al
notic
strong
induct
ex
vivo
infect
human
lung
reduc
tissu
pretreat
antiinflammatori
drug
budenosid
interestingli
steroid
reduc
induct
furthermor
reduc
presenc
intracellular
bacteria
tissu
hitherto
unexplor
mechan
ctype
lectin
receptor
recent
found
express
apic
human
bronchial
alveolar
epithelium
heyl
et
al
particip
proinflammatori
activ
human
lung
tissu
addit
classic
innat
immun
receptor
tlr
need
determin
subsequ
studi
group
dromann
et
al
use
two
clinic
isol
one
isol
copd
patient
invas
diseas
one
patient
without
copd
invas
strain
infect
lung
epitheli
cell
howev
aec
subtyp
identifi
studi
notabl
author
observ
moder
induct
strong
upregul
bmp
activin
membranebound
inhibitor
bambi
alveolar
wall
epithelium
accompani
mapktrigg
induct
proinflammatori
mediat
import
mediat
inflammatori
remodel
event
lung
elev
level
bambi
protein
plasma
observ
copd
patient
zhang
et
al
patient
increas
bambi
express
human
cell
membran
note
enhanc
plasma
bambi
level
copd
posit
correl
increas
plasma
level
ratio
indic
impair
pathway
promot
inflamm
copd
zhang
et
al
furthermor
studi
lung
idiopath
pulmonari
fibrosi
patient
mous
model
bleomycinrel
lung
fibrosi
murphi
et
al
demonstr
increas
level
bambi
relat
bmp
accessori
protein
noggin
lung
suggest
role
molecul
inflammatori
fibrot
lung
injuri
sinc
studi
suggest
role
relat
molecul
acut
lung
infect
iavrel
pneumonia
furuya
et
al
wood
et
al
iavbacteri
coinfect
li
et
al
detail
analysi
function
molecul
human
lung
highli
desir
legionella
pneumophila
l
pneumophila
caus
agent
legionnair
diseas
inhal
contamin
water
droplet
caus
diseas
outbreak
public
health
signific
phin
et
al
bacterium
interact
human
host
releas
extracellular
proinflammatori
outer
membran
vesicl
omv
use
doticm
type
ivb
transloc
system
inject
effector
protein
infect
cell
ensming
creat
replic
nich
avoid
fusion
phagosom
lysosom
interact
endoplasm
traffic
prashar
terebiznik
induc
massiv
proinflammatori
activ
human
lung
epithelium
vitro
schmeck
et
al
et
al
start
investig
legionella
infect
human
lung
tissu
use
wildtyp
strain
corbi
dotaneg
mutant
defect
doticm
type
ivb
transloc
system
furthermor
explor
role
omv
suspect
induc
massiv
lung
cell
activ
galka
et
al
show
extracellular
adhes
alveolar
epitheli
barrier
took
place
legionella
enter
macrophag
wherea
wildtyp
bacteria
multipli
within
h
dotaneg
bacteria
could
replic
within
tissu
note
infect
caus
damag
infect
alveolar
wall
bacteria
defici
dota
induc
less
damag
wildtyp
bacteria
highlight
import
virul
system
surfac
cytoplasm
decor
omv
suggest
cell
particularli
target
proinflammatori
legionella
vesicl
omv
induc
damag
lung
compar
caus
wildtyp
bacteria
shed
light
possibl
import
role
omv
legionella
pathogenesi
use
transcriptom
analysi
author
show
differenti
express
gene
legionellainfect
human
lung
tissu
includ
gene
relat
extracellular
protein
compon
immun
respons
lipoprotein
transport
protein
pathophysiolog
role
exampl
observ
downregul
protein
content
immunoregulatori
uteroglobin
member
secretoglobin
superfamili
mukherje
et
al
downregul
marco
class
scaveng
receptor
seem
involv
exampl
pathogenesi
pneumococcu
dorrington
et
al
remain
unknown
addit
character
way
vacuol
format
naujok
et
al
activ
innat
immun
receptor
cunha
zamboni
take
place
origin
human
lung
tissu
would
great
interest
oblig
intracellular
pathogen
coxiella
burnetii
caus
q
fever
diseas
start
flulik
symptom
case
prolong
infect
may
proceed
sever
endocard
similar
legionnair
diseas
public
health
system
notic
q
fever
mostli
form
local
outbreak
result
inhal
contamin
aerosol
farm
domest
anim
particular
sheep
goat
cilloniz
et
al
coxiella
replic
within
acid
lysosomelik
parasitophor
vacuol
pv
mostli
macrophag
use
doticm
type
iv
secretionsystembas
molecul
deliveri
host
cell
hijack
host
cell
signal
cascad
therebi
creat
replic
nich
moffatt
et
al
graham
et
al
compar
behavior
avirul
c
burnetii
nmii
clone
frequent
use
laboratori
strain
virul
c
burnetii
human
precisioncut
lung
slice
although
singl
bacteria
detect
alveolar
epithelium
bacteria
replic
suffici
note
live
avirul
bacteria
induc
liber
wherea
virul
bacteria
subsequ
use
human
author
found
humanspecif
noncanon
inflammasom
depend
might
induc
releas
without
induct
pyroptosi
sinc
humanspecif
protein
undetect
human
macrophagelik
cell
line
model
mous
macrophag
respond
liber
c
burnettii
infect
cunha
et
al
discoveri
essenti
base
use
origin
human
tissu
notabl
sinc
numer
studi
involv
use
avirul
virul
c
burnettii
indic
wide
ident
intracellular
behavior
bacteria
moffatt
et
al
investig
primari
human
tissu
cell
need
order
discov
way
virul
c
burnetii
suppress
product
therebi
inhibit
one
power
proinflammatori
mediat
host
enorm
clinic
import
continu
emerg
new
influenza
strain
iav
lai
et
al
trombetta
et
al
variou
worker
investig
iav
infect
human
lung
tissu
research
focus
report
viral
replic
tissu
tropism
tissu
activ
sens
cytokin
chemokin
liber
knowledg
level
effici
emerg
iav
replic
human
lung
tissu
enorm
import
estim
potenti
spread
commun
gaug
potenti
viru
caus
harm
lung
exampl
avian
iav
caus
typic
sever
human
infect
high
fatal
rate
mani
year
lai
et
al
use
human
lung
tissu
ex
vivo
infect
iav
sever
group
demonstr
strong
viral
replic
rw
chan
et
al
hock
et
al
nichol
et
al
weinheim
et
al
compar
even
higher
observ
classic
pandem
strain
iav
weinheim
et
al
first
pandem
centuri
start
novel
swineorigin
iav
viru
novel
swineorigin
influenza
et
al
case
viru
caus
diseas
moder
sever
observ
season
influenza
peiri
et
al
accord
compar
highli
virul
iav
strain
classic
pandem
strain
iav
viru
show
intermedi
replic
ex
vivo
infect
human
lung
tissu
mc
chan
et
al
weinheim
et
al
wu
et
al
zhang
et
al
thu
reflect
moder
diseas
caus
human
new
iav
viru
result
sequenti
reassort
duck
chicken
shown
infect
human
be
sinc
origin
eastern
china
viru
caus
repeat
wave
outbreak
thu
rais
concern
pandem
threat
zhou
et
al
two
report
reveal
iav
effici
replic
human
lung
tissu
mc
chan
et
al
knepper
et
al
notic
wherea
viru
isol
fatal
human
infect
replic
compar
season
iav
classic
avian
subtyp
virus
propag
poorli
indic
new
viru
well
adapt
replic
human
host
knepper
et
al
agreement
sever
studi
demonstr
iav
strain
adapt
human
classic
swine
avian
strain
propag
effici
human
materi
mc
chan
et
al
knepper
et
al
weinheim
et
al
wu
et
al
zhang
et
al
overal
ex
vivo
model
use
studi
seem
robustli
reflect
capac
infect
propag
human
infect
host
cell
iav
result
numer
alter
cell
function
rang
releas
immuneregul
mediat
chang
sodium
pump
activ
final
kill
iavinfect
cell
herold
et
al
short
et
al
thu
identif
primari
target
cell
iav
human
lung
primari
import
estim
possibl
effect
cell
damag
organ
function
investig
possibl
cellbas
intervent
irrespect
viru
strain
use
ex
vivo
infect
model
report
identifi
aec
ii
cell
primari
replic
nich
peripher
human
lung
fig
mc
chan
et
al
hock
et
al
knepper
et
al
weinheim
et
al
zhang
et
al
patient
lung
fibrosi
typic
show
aec
ii
hyperplasia
fernandez
eickelberg
hock
et
al
demonstr
massiv
infect
aec
ii
cell
fibrot
lung
fujino
et
al
notic
increas
iav
replic
aec
ii
cell
deriv
patient
pulmonari
fibrosi
thu
indic
aec
ii
cell
primari
target
cell
iav
human
lung
contrast
presenc
viral
antigen
detect
much
less
frequent
human
alveolar
macrophag
mc
chan
et
al
weinheim
et
al
nevertheless
cell
import
immun
respons
iav
halstead
chroneo
although
iav
particl
identifi
endotheli
cell
fatal
case
ru
et
al
vitro
experi
indic
iav
propag
endotheli
cell
wang
et
al
endothelium
might
significantli
contribut
cours
diseas
teijaro
et
al
iav
antigen
detect
ex
vivo
model
discuss
tissu
respond
iav
infect
releas
multipl
immunomodulatori
mediat
includ
interferongamma
induc
protein
kda
interferonbeta
somewhat
strainspecif
manner
knepper
et
al
weinheim
et
al
wu
et
al
howev
subsequ
strainrel
analysi
mediat
express
still
lack
limit
inform
avail
mediat
origin
wu
et
al
experi
chemic
inhibitor
suggest
import
role
mapk
regul
inflammatori
mediat
express
wu
et
al
iav
seem
interfer
express
patternrecognit
receptor
retino
acidinduc
gene
rigi
wu
et
al
patient
copd
prone
iav
infect
iav
vaccin
highli
warrant
suffer
copd
sehatzadeh
use
human
lung
explant
expos
cigarett
smoke
extract
iav
infect
wu
et
al
demonstr
alter
ifn
express
iavmedi
rigi
upregul
suggest
smoke
impair
host
respons
iav
model
might
use
test
new
therapeut
approach
indic
report
chan
et
al
rw
bind
sialic
acid
depend
viral
strain
host
cell
membran
integr
step
iav
infect
process
rw
chan
et
al
demonstr
induc
desialyl
sialic
acid
ex
vivo
human
lung
tissu
two
dose
treatment
given
h
postinfect
suffici
block
infect
ex
vivo
lung
tissu
cultur
human
adenoviru
belong
adenovirida
subgroup
b
caus
pneumonia
system
diseas
immunocompromis
nonimmunocompromis
host
mainli
region
outbreak
ng
et
al
scott
et
al
addit
human
pathogen
recombin
adenovirus
attract
interest
research
sever
year
ago
promis
tool
gene
therapi
lack
suitabl
anim
ginsberg
et
al
cell
cultur
jogler
et
al
model
support
human
hadv
replic
hamper
research
progress
booth
et
al
thu
use
human
ex
vivo
infect
model
human
show
effici
viral
replic
provok
activ
erk
kinas
erk
inhibit
block
releas
subsequ
studi
wu
et
al
group
show
liber
infect
tissu
multicolor
immunostain
document
infect
aeci
aecii
cell
author
identifi
lung
aec
primari
sourc
wherea
found
epitheli
cell
overal
model
give
solid
basi
assess
hadv
viral
replic
patholog
infect
coronavirus
cov
human
primarili
target
upper
respiratori
tract
case
induc
rather
mild
selflimit
diseas
common
cold
su
et
al
howev
sarscov
merscov
differ
cov
sarscov
caus
global
outbreak
sever
respiratori
diseas
kill
peopl
illustr
potenti
worldwid
impact
new
interspeci
transmiss
highli
pathogen
zoonot
viru
peiri
et
al
import
initi
step
understand
emerg
viral
infect
lung
identif
host
cell
receptor
primari
target
cell
use
human
sarscovinfect
lung
tissu
slice
function
angiotensinconvert
enzym
human
receptor
sarscov
could
substanti
vs
chan
et
al
furthermor
result
indic
subpopul
lung
cell
express
stemprogenitor
cell
marker
neg
cytokeratin
surfact
may
import
target
cell
sarscov
human
lung
chen
et
al
howev
way
sarscov
interact
human
lung
alveolu
far
away
understood
research
effort
elucid
pathobiolog
paralyz
tempor
distanc
outbreak
merscov
origin
name
human
coronavirusemc
emerg
new
cov
caus
acut
respiratori
syndrom
human
fehr
et
al
mohd
et
al
zumla
et
al
probabl
origin
bat
merscov
infect
endem
dromedari
camel
popul
east
africa
middl
east
mohd
et
al
human
case
base
dromedari
camel
human
transmiss
although
circumst
signific
humantohuman
transmiss
also
occur
cho
et
al
drosten
et
al
merscov
use
receptor
human
dipeptidyl
peptidas
raj
et
al
present
frequent
use
anim
model
gretebeck
subbarao
sutton
subbarao
thu
imped
analysi
complex
lung
tissu
hock
et
al
rw
chan
et
al
use
ex
vivo
infect
human
lung
assess
viral
replic
cellular
tropism
merscov
group
infect
tissu
origin
human
merscov
erasmu
medic
center
strain
group
rw
chan
expand
observ
strain
isol
dromedari
group
show
strong
viral
replic
lung
tissu
bronchial
epitheli
cell
aeci
aecii
cell
endotheli
cell
shown
infect
rw
chan
et
al
hock
et
al
inde
electron
microscopi
show
presenc
merscov
aeci
aecii
cell
hock
et
al
presenc
viru
particl
basal
lamina
intact
aec
suggest
basolater
releas
merscov
hock
et
al
notabl
report
show
evid
infect
present
cell
type
infect
hock
et
al
broad
receptor
express
might
one
major
factor
observ
widespread
cellular
tropism
merscov
gain
insight
mechanist
caus
lung
failur
merscov
hock
et
al
assess
cell
death
epitheli
cell
integr
alveolar
tight
junction
protein
occludin
detach
apoptot
aecii
alveolar
base
membran
disrupt
alveolar
tight
junction
indic
disintegr
occludin
protein
band
indic
structur
lung
damag
caus
merscov
fig
notabl
first
publish
autopsi
perform
fatal
case
merscov
essenti
confirm
result
ex
vivo
model
respect
viral
tissu
tropism
damag
ng
et
al
persist
reintroduct
viru
human
popul
lack
specif
therapi
ongo
need
exist
investig
merscov
interact
human
host
present
studi
indic
ex
vivo
infect
human
lung
tissu
use
investig
basic
principl
pathogenhost
interact
lung
great
advantag
model
possibl
use
wildtyp
patient
isol
bacteria
virus
investig
gener
pathogen
risk
assess
emerg
pathogen
eg
new
zoonot
virus
origin
threedimension
tissu
mani
studi
focu
pathogen
replic
cellular
tropism
tissu
activ
sens
releas
immunomodulatori
factor
despit
obviou
valu
mani
area
human
tissu
cultur
per
se
improv
particular
mani
direct
taken
investig
infecti
lung
diseas
one
import
issu
need
know
detail
sever
level
box
studi
involv
use
peripher
alveolar
lung
materi
obtain
surgeri
lung
cancer
group
investig
lung
tissu
use
transplant
although
tumorfre
tissu
use
rule
presenc
tumor
lung
alter
tissu
respons
exampl
mechan
ventil
explant
affect
sampl
respons
donor
lung
tissu
might
long
histori
smoke
might
suffer
addit
diseas
howev
sampl
number
laboratori
increas
detail
stratif
patient
histori
analysi
tissu
respons
may
help
us
understand
way
smoke
copd
asthma
diabet
mellitu
chronic
heart
diseas
lead
increas
suscept
pneumonia
torr
et
al
lung
tissu
contain
huge
varieti
cellular
compon
even
nowaday
new
cell
type
identifi
frank
et
al
need
use
robust
technolog
advanc
cell
sort
fujino
et
al
gross
et
al
microscopi
identifi
cell
present
sampl
investig
chang
popul
cultur
time
lungpathogen
interact
step
prerequisit
indepth
analysi
role
hitherto
neglect
cell
respons
lung
infect
exampl
piet
et
al
use
human
lung
tissuederiv
cell
investig
specif
function
cell
studi
indic
human
lung
might
harbor
local
virusspecif
epitheli
cell
might
protect
lung
recur
iav
infect
piet
et
al
techniqu
laserassist
cell
pick
extract
singl
cell
infect
lung
tissu
fink
et
al
combin
recent
develop
assay
singlecel
transcriptom
analysi
bell
eberwin
grun
et
al
hodn
weltzien
macaulay
et
al
might
help
expand
knowledg
cellspecif
respons
human
lung
inde
combin
cuttingedg
technolog
complex
human
sampl
challeng
need
strong
interdisciplinari
collabor
microscopybas
document
livedead
stain
cell
subsequ
threedimension
reconstruct
help
us
gain
insight
tissu
viabil
time
specif
effect
pathogen
virul
factor
eg
pli
releas
pneumocooci
preserv
complex
threedimension
structur
lung
one
great
advantag
model
highend
microscopi
key
obtain
inform
pathogenhost
interact
complex
organ
architectur
unfortun
human
lung
tissu
contain
strong
autofluoresc
structur
eg
collagen
elastin
caus
signific
overlap
fluorophor
emiss
spectra
spectral
confoc
microscopi
use
achiev
higher
signaltonois
ratio
demonstr
studi
hock
et
al
b
szymanski
et
al
weinheim
et
al
hand
autofluoresc
may
use
visual
tissu
morpholog
cellular
dynam
human
lung
tissu
perform
autofluoresc
multiphoton
microscopi
kretschmer
et
al
technic
reason
exist
realtim
imag
pulmonari
reaction
combin
micropunctur
techniqu
previous
success
use
anim
experi
islam
et
al
kreisel
et
al
looney
bhattacharya
westphalen
et
al
also
use
dissect
intraalveolar
hostpathogen
interact
ex
vivo
human
lung
model
next
step
advanc
phenomenolog
studi
mechanist
investig
order
improv
analyt
potenc
model
beyond
use
chemic
inhibitor
test
innov
antiinfect
drug
viral
transform
mcbride
et
al
allow
cellspecif
function
analysi
possibl
strategi
combin
gene
edit
approach
system
chen
goncalv
wang
qi
therebi
permit
mechanist
studi
gener
need
abl
establish
longer
durat
tissu
cultiv
exampl
viral
transform
subsequ
gene
edit
togeth
studi
address
tissu
injuri
repair
would
profit
expand
observ
time
rapid
emerg
sophist
microfluid
system
esch
et
al
better
mimick
organ
suppli
possibl
includ
physic
forc
might
lead
longer
period
lung
tissu
cultiv
final
studi
hamper
limit
tissu
avail
limit
could
least
part
overcom
rigor
improv
human
lungspecif
cryopreserv
method
baatz
et
al
bai
et
al
rosner
et
al
beyond
analyt
power
model
wish
stress
use
human
lung
tissu
reduc
burden
anim
experi
contribut
principl
replac
reduc
refin
anim
experi
russel
overal
ex
vivo
infect
model
human
lung
tissu
today
great
valu
investig
pneumoniarel
hostpathogen
interact
combin
model
avail
cuttingedg
technolog
booster
mechanist
understand
pneumonia
human
